← All trials
NCT06138470
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 30, 2022
- Primary completion
- Jul 30, 2024
- Completion date
- Jul 30, 2024
- First posted
- Nov 18, 2023
- Last posted
- Nov 18, 2023
- Enrollment
- 240
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Comercial Quimica Masso, S.ALead sponsor
- Université catholique de LouvainCollaborator
- Université catholique de LouvainOverall official - principal investigator
- Université catholique de LouvainStudy chair
- Université catholique de LouvainStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.